These terms and conditions govern your use of the website alphaminr.com and its related services.
These Terms and Conditions (“Terms”) are a binding contract between you and Alphaminr, (“Alphaminr”, “we”, “us” and “service”). You must agree to and accept the Terms. These Terms include the provisions in this document as well as those in the Privacy Policy. These terms may be modified at any time.
Your subscription will be on a month to month basis and automatically renew every month. You may terminate your subscription at any time through your account.
We will provide you with advance notice of any change in fees.
You represent that you are of legal age to form a binding contract. You are responsible for any
activity associated with your account. The account can be logged in at only one computer at a
time.
The Services are intended for your own individual use. You shall only use the Services in a
manner that complies with all laws. You may not use any automated software, spider or system to
scrape data from Alphaminr.
Alphaminr is not a financial advisor and does not provide financial advice of any kind. The service is provided “As is”. The materials and information accessible through the Service are solely for informational purposes. While we strive to provide good information and data, we make no guarantee or warranty as to its accuracy.
TO THE EXTENT PERMITTED BY APPLICABLE LAW, UNDER NO CIRCUMSTANCES SHALL ALPHAMINR BE LIABLE TO YOU FOR DAMAGES OF ANY KIND, INCLUDING DAMAGES FOR INVESTMENT LOSSES, LOSS OF DATA, OR ACCURACY OF DATA, OR FOR ANY AMOUNT, IN THE AGGREGATE, IN EXCESS OF THE GREATER OF (1) FIFTY DOLLARS OR (2) THE AMOUNTS PAID BY YOU TO ALPHAMINR IN THE SIX MONTH PERIOD PRECEDING THIS APPLICABLE CLAIM. SOME STATES DO NOT ALLOW THE EXCLUSION OR LIMITATION OF INCIDENTAL OR CONSEQUENTIAL OR CERTAIN OTHER DAMAGES, SO THE ABOVE LIMITATION AND EXCLUSIONS MAY NOT APPLY TO YOU.
If any provision of these Terms is found to be invalid under any applicable law, such provision shall not affect the validity or enforceability of the remaining provisions herein.
This privacy policy describes how we (“Alphaminr”) collect, use, share and protect your personal information when we provide our service (“Service”). This Privacy Policy explains how information is collected about you either directly or indirectly. By using our service, you acknowledge the terms of this Privacy Notice. If you do not agree to the terms of this Privacy Policy, please do not use our Service. You should contact us if you have questions about it. We may modify this Privacy Policy periodically.
When you register for our Service, we collect information from you such as your name, email address and credit card information.
Like many other websites we use “cookies”, which are small text files that are stored on your computer or other device that record your preferences and actions, including how you use the website. You can set your browser or device to refuse all cookies or to alert you when a cookie is being sent. If you delete your cookies, if you opt-out from cookies, some Services may not function properly. We collect information when you use our Service. This includes which pages you visit.
We use Google Analytics and we use Stripe for payment processing. We will not share the information we collect with third parties for promotional purposes. We may share personal information with law enforcement as required or permitted by law.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Preliminary Proxy Statement
|
|||
|
|
|
Confidential, For Use of the Commission Only (as permitted by Rule 14a-6(e) (2))
|
|||
|
X
|
|
Definitive Proxy Statement
|
|||
|
|
|
Definitive Additional Materials
|
|||
|
|
|
Soliciting Material Pursuant to §240.14a-12
|
|||
|
T. Rowe Price Group, Inc.
|
|||||
|
(Name of Registrant as Specified in Its Charter)
|
|||||
|
(Name of Person(s) Filing Proxy Statement, if Other Than the Registrant)
|
|||||
|
Payment of Filing Fee (Check the appropriate box):
|
|||||
|
X
|
|
No fee required.
|
|||
|
|
|
Fee computed on table below per Exchange Act Rules 14a-6(i) (1) and 0-11.
|
|||
|
|
|
(1
|
)
|
|
Title of each class of securities to which transaction applies:
|
|
|
|
(2
|
)
|
|
Aggregate number of securities to which transaction applies:
|
|
|
|
(3
|
)
|
|
Per unit price or other underlying value of transaction computed pursuant to Exchange Act Rule 0-11 (set forth the amount on which the filing fee is calculated and state how it was determined):
|
|
|
|
(4
|
)
|
|
Proposed maximum aggregate value of transaction:
|
|
|
|
(5
|
)
|
|
Total Fee Paid:
|
|
|
|
Fee paid previously with preliminary materials:
|
|||
|
|
|
Check box if any part of the fee is offset as provided by Exchange Act Rule 0-11(a)(2) and identify the filing for which the offsetting fee was paid previously. Identify the previous filing by registration statement number, or the Form or Schedule and the date of its filing.
|
|||
|
|
|
(1
|
)
|
|
Amount previously paid:
|
|
|
|
(2
|
)
|
|
Form, Schedule or Registration Statement No:
|
|
|
|
(3
|
)
|
|
Filing Party:
|
|
|
|
(4
|
)
|
|
Date Filed:
|
|
|
|
|
|
|
|
|
YOUR VOTE IS IMPORTANT!
|
|
Please execute and return the enclosed proxy promptly whether or not you plan to attend
the T. Rowe Price Group, Inc. 2015 Annual Meeting of Stockholders.
|
|
|
|
|
|
|
||
|
|
||
|
|
||
|
|
||
|
|
||
|
|
||
|
|
||
|
|
||
|
|
||
|
|
||
|
|
||
|
4
|
|
|
|
|
||
|
|
||
|
|
||
|
|
||
|
|
||
|
|
||
|
|
||
|
|
||
|
|
||
|
|
||
|
2014 Grants of Plan-Based Awards Table
|
|
|
|
Outstanding Equity Awards Table at December 31, 2014
|
|
|
|
2014 Option Exercises and Stock Vested Table
|
|
|
|
|
||
|
|
||
|
|
||
|
Proposal 3: Ratification of the Appointment of KPMG LLP as our Independent Registered Public Accounting Firm for 2015
|
|
|
|
45
|
|
|
|
|
||
|
|
||
|
Stockholder Proposals for the 2016 Annual Meeting
|
|
|
|
|
||
|
|
||
|
|
||
|
•
|
Election of Directors
. To be elected to serve until our
2016
annual meeting and until his or her successor is elected and qualifies, a director nominee (see page
4
) must obtain the affirmative vote of a majority of the total votes cast at the Meeting for and against such nominee. Please see page
3
for a discussion of our majority voting provisions. Stockholders may not cumulate their votes in director elections. Abstentions and broker non-votes are not considered votes cast and will have no effect on the outcome of the election of directors.
|
|
•
|
Advisory Vote on the Compensation Paid to our Named Executive Officers
. Approval of this proposal requires the affirmative vote of a majority of the total votes cast at the Meeting for or against this proposal. Abstentions and broker non-votes are not considered votes cast and will have no effect on the outcome of this matter.
|
|
•
|
Ratify the Appointment of KPMG LLP
. Approval of this proposal requires the affirmative vote of a majority of the total votes cast at the Meeting for or against this proposal. Abstentions are not considered votes cast and will have no effect on the outcome of this matter.
|
|
1)
|
by using the Internet
– as prompted by the menu found at
www.proxyvote.com
, follow the instructions to obtain your records and create an electronic ballot. Please have your Notice or proxy card and the last four digits of your Social Security Number or tax identification number available when you access this voting site;
|
|
2)
|
by telephone
– call the toll-free telephone number on the proxy card or voting instruction form and then follow the voice instructions; or
|
|
3)
|
by mail
– request a paper proxy card in accordance with the instructions contained in the Notice and then complete, sign, and date the proxy card and return it in the postage-paid envelope provided.
|
|
•
|
relationships where a director or an immediate family member of a director purchases or acquires investment services, investment securities, or similar products and services from the Company or one of its sponsored mutual funds so long as the relationship is on terms consistent with those generally available to other persons doing business with the Company, its subsidiaries, or its sponsored investment products; and
|
|
•
|
relationships where a corporation, partnership, or other entity with respect to which a director or an immediate family member of a director is an officer, director, employee, partner, or member purchases services from the Company, including investment management or defined contribution retirement plan services, on terms consistent with those generally available to other entities doing business with the Company or its subsidiaries.
|
|
•
|
determining the compensation of the chief executive officer and other executive officers;
|
|
•
|
reviewing and approving general salary and compensation policies for the rest of our senior officers;
|
|
•
|
overseeing the administration of our Annual Incentive Compensation Pool, equity incentive plans, and employee stock purchase plan;
|
|
•
|
assisting management in designing new compensation policies and plans; and
|
|
•
|
reviewing and discussing the Compensation Discussion and Analysis and other compensation disclosures with management.
|
|
•
|
An annual retainer of
$100,000
;
|
|
•
|
A fee of
$1,500
for each committee meeting attended;
|
|
•
|
A fee of
$15,000
for the Lead Director;
|
|
•
|
A fee of
$20,000
and
$5,000
, for the chairperson of the Audit Committee and each Audit Committee member, respectively;
|
|
•
|
A fee of
$10,000
for the chairperson of the Executive Compensation Committee;
|
|
•
|
A fee of
$10,000
for the chairperson of the Nominating and Corporate Governance Committee;
|
|
•
|
Directors and all U.S. employees of Price Group and its subsidiaries are eligible to have our sponsored T. Rowe Price Foundation match personal gifts up to an annual limit to qualified charitable organizations. For
2014
, non-employee directors were eligible to have up to $10,000 matched;
|
|
•
|
The reimbursement of reasonable out-of-pocket expenses incurred in connection with their travel to and from, and attendance at each meeting of the Board of Directors and its committees and related activities, including director education courses and materials; and
|
|
•
|
The reimbursement of spousal travel to and participation in events held in connection with the annual joint Price Group and Price funds' Board of Directors meeting.
|
|
Name
|
Fees Earned or Paid
in Cash
|
Stock
Awards
|
Option Awards
|
All Other Compensation
|
Total
|
||||||||||
|
(2)(3)(4)
|
(2)(3)(4)
|
(5)
|
|||||||||||||
|
Mark S. Bartlett
|
$
|
121,500
|
|
$
|
202,025
|
|
$
|
—
|
|
$
|
10,000
|
|
$
|
333,525
|
|
|
James T. Brady
(6)
|
$
|
39,500
|
|
$
|
—
|
|
$
|
—
|
|
$
|
10,000
|
|
$
|
49,500
|
|
|
Mary K. Bush
|
$
|
118,000
|
|
$
|
216,105
|
|
$
|
—
|
|
$
|
3,950
|
|
$
|
338,055
|
|
|
Donald B. Hebb, Jr.
|
$
|
118,000
|
|
$
|
202,025
|
|
$
|
—
|
|
$
|
10,000
|
|
$
|
330,025
|
|
|
Dr. Freeman A. Hrabowski, III
|
$
|
121,500
|
|
$
|
7,603
|
|
$
|
185,304
|
|
$
|
10,000
|
|
$
|
324,407
|
|
|
Robert F. MacLellan
|
$
|
136,500
|
|
$
|
7,753
|
|
$
|
185,304
|
|
$
|
10,000
|
|
$
|
339,557
|
|
|
Olympia J. Snowe
|
$
|
115,000
|
|
$
|
202,025
|
|
$
|
—
|
|
$
|
10,000
|
|
$
|
327,025
|
|
|
Dr. Alfred Sommer
|
$
|
143,000
|
|
$
|
221,268
|
|
$
|
—
|
|
$
|
10,000
|
|
$
|
374,268
|
|
|
Dwight S. Taylor
|
$
|
131,500
|
|
$
|
236,975
|
|
$
|
—
|
|
$
|
10,000
|
|
$
|
378,475
|
|
|
Anne Marie Whittemore
|
$
|
118,000
|
|
$
|
208,714
|
|
$
|
—
|
|
$
|
10,000
|
|
$
|
336,714
|
|
|
(1)
|
Includes only those columns relating to compensation awarded to, earned by, or paid to non-employee directors for their services in
2014
. All other columns have been omitted.
|
|
(2)
|
Represents the aggregate grant date fair value of equity awards granted to each non-employee director in
2014
. The grant date fair value of stock awards was measured using the grant date market price per share of Price Group's common stock. The grant date fair value of options was computed using the Black-Scholes option-pricing model and the following weighted average assumptions:
|
|
Expected life in years
|
|
6.8
|
|
Expected volatility
|
|
31.5%
|
|
Dividend yield
|
|
2.2%
|
|
Risk-free interest rate
|
|
2.2%
|
|
(3)
|
The following table represents the equity awards granted to each of the non-employee directors named above in
2014
and their corresponding grant date fair value as determined by the methodologies discussed in footnote two above. The holders of stock units also receive dividend equivalents in the form of additional vested stock units on each of the Company's dividend payment dates.
|
|
Director
|
Grant Date
|
Number of Restricted Shares
|
Number of Restricted Units
|
Number of Securities Underlying Options
|
Exercise Price of Option Awards per Share
|
Grant Date Fair Value of Stock and Option Awards
|
|||||||
|
Messrs. Bartlett and Hebb
|
4/29/2014
|
1,250
|
|
|
|
|
$
|
102,250
|
|
||||
|
|
10/28/2014
|
1,250
|
|
|
|
|
$
|
99,775
|
|
||||
|
Ms. Bush
|
3/28/2014
|
|
36
|
|
|
|
$
|
2,944
|
|
||||
|
|
4/29/2014
|
|
1,250
|
|
|
|
$
|
102,250
|
|
||||
|
|
6/27/2014
|
|
42
|
|
|
|
$
|
3,510
|
|
||||
|
|
9/29/2014
|
|
45
|
|
|
|
$
|
3,528
|
|
||||
|
|
10/28/2014
|
|
1,250
|
|
|
|
$
|
99,775
|
|
||||
|
|
12/30/2014
|
|
47
|
|
|
|
$
|
4,098
|
|
||||
|
Director
|
Grant Date
|
Number of Restricted Shares
|
Number of Restricted Units
|
Number of Securities Underlying Options
|
Exercise Price of Option Awards per Share
|
Grant Date Fair Value of Stock and Option Awards
|
|||||||
|
Dr. Hrabowski
|
3/28/2014
|
|
23
|
|
|
|
$
|
1,885
|
|
||||
|
|
4/29/2014
|
|
|
4,200
|
|
$
|
81.80
|
|
$
|
97,230
|
|
||
|
|
6/27/2014
|
|
23
|
|
|
|
$
|
1,896
|
|
||||
|
|
9/29/2014
|
|
24
|
|
|
|
$
|
1,906
|
|
||||
|
|
10/28/2014
|
|
|
4,200
|
|
$
|
79.82
|
|
$
|
88,074
|
|
||
|
|
12/30/2014
|
|
22
|
|
|
|
$
|
1,916
|
|
||||
|
Mr. MacLellan
|
3/28/2014
|
|
24
|
|
|
|
$
|
1,923
|
|
||||
|
|
4/29/2014
|
|
|
4,200
|
|
$
|
81.80
|
|
$
|
97,230
|
|
||
|
|
6/27/2014
|
|
23
|
|
|
|
$
|
1,933
|
|
||||
|
|
9/29/2014
|
|
25
|
|
|
|
$
|
1,943
|
|
||||
|
|
10/28/2014
|
|
|
4,200
|
|
$
|
79.82
|
|
$
|
88,074
|
|
||
|
|
12/30/2014
|
|
22
|
|
|
|
$
|
1,954
|
|
||||
|
Ms. Snowe
|
4/29/2014
|
1,250
|
|
|
|
|
$
|
102,250
|
|
||||
|
|
10/28/2014
|
1,250
|
|
|
|
|
$
|
99,775
|
|
||||
|
Dr. Sommer
|
3/28/2014
|
|
58
|
|
|
|
$
|
4,772
|
|
||||
|
|
4/29/2014
|
1,250
|
|
|
|
|
$
|
102,250
|
|
||||
|
|
6/27/2014
|
|
57
|
|
|
|
$
|
4,798
|
|
||||
|
|
9/29/2014
|
|
61
|
|
|
|
$
|
4,823
|
|
||||
|
|
10/28/2014
|
1,250
|
|
|
|
|
$
|
99,775
|
|
||||
|
|
12/30/2014
|
|
56
|
|
|
|
$
|
4,850
|
|
||||
|
Mr. Taylor
|
3/28/2014
|
|
99
|
|
|
|
$
|
8,120
|
|
||||
|
|
4/29/2014
|
|
1,250
|
|
|
|
$
|
102,250
|
|
||||
|
|
6/27/2014
|
|
104
|
|
|
|
$
|
8,713
|
|
||||
|
|
9/29/2014
|
|
112
|
|
|
|
$
|
8,759
|
|
||||
|
|
10/28/2014
|
|
1,250
|
|
|
|
$
|
99,775
|
|
||||
|
|
12/30/2014
|
|
108
|
|
|
|
$
|
9,358
|
|
||||
|
Ms. Whittemore
|
3/28/2014
|
|
14
|
|
|
|
$
|
1,111
|
|
||||
|
|
4/29/2014
|
|
1,250
|
|
|
|
$
|
102,250
|
|
||||
|
|
6/27/2014
|
|
20
|
|
|
|
$
|
1,667
|
|
||||
|
|
9/29/2014
|
|
21
|
|
|
|
$
|
1,676
|
|
||||
|
|
10/28/2014
|
|
1,250
|
|
|
|
$
|
99,775
|
|
||||
|
|
12/30/2014
|
|
26
|
|
|
|
$
|
2,235
|
|
||||
|
(4)
|
The following table represents the aggregate number of equity awards outstanding as of
December 31, 2014
.
|
|
Director
|
Unvested Stock Awards
|
Unvested Stock Units
|
Unexercised Option Awards
|
Total
|
|
Vested Stock Units
|
|||||
|
Mark S. Bartlett
|
2,500
|
|
|
|
|
|
2,500
|
|
|
|
|
|
Mary K. Bush
|
|
|
2,500
|
|
|
|
2,500
|
|
|
6,861
|
|
|
Donald B. Hebb, Jr.
|
2,500
|
|
|
|
12,186
|
|
14,686
|
|
|
|
|
|
Dr. Freeman A. Hrabowski, III
|
|
|
|
|
8,400
|
|
8,400
|
|
|
4,377
|
|
|
Robert F. MacLellan
|
|
|
|
|
33,048
|
|
33,048
|
|
|
4,464
|
|
|
Olympia J. Snowe
|
2,500
|
|
|
|
|
|
2,500
|
|
|
|
|
|
Dr. Alfred Sommer
|
2,500
|
|
|
|
|
|
2,500
|
|
|
11,079
|
|
|
Dwight S. Taylor
|
|
|
2,500
|
|
|
|
2,500
|
|
|
18,876
|
|
|
Anne Marie Whittemore
|
|
|
2,500
|
|
60,930
|
|
63,430
|
|
|
2,605
|
|
|
(5)
|
Personal gifts matched by our sponsored T. Rowe Price Foundation to qualified charitable organizations.
|
|
(6)
|
Represents fees for a partial year. Mr. Brady retired from the Board at the 2014 annual meeting of stockholders.
|
|
•
|
demonstrate unimpeachable character and integrity;
|
|
•
|
have sufficient time to carry out their duties;
|
|
•
|
have experience at senior levels in areas of expertise helpful to the Company and consistent with the objective of having a diverse and well-rounded Board; and
|
|
•
|
have the willingness and commitment to assume the responsibilities required of a director of the Company.
|
|
Dr. Alfred Sommer, Chairman
|
|
Mary K. Bush
|
|
Donald B. Hebb, Jr.
|
|
Olympia J. Snowe
|
|
Anne Marie Whittemore
|
|
Name and Address
|
Amount and Nature of Beneficial Ownership
|
|
Percent of Class
|
|
|
BlackRock, Inc.
|
|
|
|
|
|
55 East 52nd Street
|
|
|
|
|
|
New York, NY 10022
|
14,122,421
|
shares
|
(1)
|
5.42%
|
|
|
|
|
|
|
|
State Street Corporation
|
|
|
|
|
|
State Street Financial Center
|
|
|
|
|
|
One Lincoln Street
|
|
|
|
|
|
Boston, MA 02111
|
13,905,456
|
shares
|
(2)
|
5.34%
|
|
|
|
|
|
|
|
The Vanguard Group
|
|
|
|
|
|
100 Vanguard Blvd.
|
|
|
|
|
|
Malvern, PA 19355
|
15,280,297
|
shares
|
(3)
|
5.86%
|
|
(1)
|
Based solely on information contained in a Schedule 13G/A filed with the SEC on
February 2, 2015
, by BlackRock, Inc. Of the
14,122,421
shares beneficially owned, BlackRock, Inc. has sole power to vote or direct the vote of
12,032,147
shares and sole power to dispose or to direct the disposition of
14,122,421
shares.
|
|
(2)
|
Based solely on information contained in a Schedule 13G filed with the SEC on
February 12, 2015
, by State Street Corporation. State Street Corporation has shared power to vote or direct the vote and shared power to dispose or direct the disposition of
13,905,456
shares.
|
|
(3)
|
Based solely on information contained in a Schedule 13G/A filed with the SEC on
February 11, 2015
, by The Vanguard Group. Of the
15,280,297
shares beneficially owned, The Vanguard Group has sole power to vote or direct the vote of
452,786
shares, sole power to dispose or to direct the disposition of
14,856,770
shares, and shared power to dispose or to direct the disposition of
423,527
shares.
|
|
Name of Beneficial Owner
|
Amount of Beneficial Ownership
|
|
Percent of Class
(1)
|
|
|
Mark S. Bartlett
|
11,200
|
|
(2)
|
*
|
|
Edward C. Bernard
|
2,449,125
|
|
(3)
|
*
|
|
Mary K. Bush
|
6,861
|
|
(4)
|
*
|
|
Donald B. Hebb, Jr.
|
75,082
|
|
(5)
|
*
|
|
Dr. Freeman A. Hrabowski, III
|
46,417
|
|
(6)
|
*
|
|
James A.C. Kennedy
|
3,321,597
|
|
(7)
|
1.3%
|
|
Robert F. MacLellan
|
29,112
|
|
(8)
|
*
|
|
Kenneth V. Moreland
|
269,793
|
|
(9)
|
*
|
|
Brian C. Rogers
|
3,010,156
|
|
(10)
|
1.2%
|
|
Olympia J. Snowe
|
6,700
|
|
(11)
|
*
|
|
Dr. Alfred Sommer
|
20,879
|
|
(12)
|
*
|
|
William J. Stromberg
|
1,281,016
|
|
(13)
|
*
|
|
Dwight S. Taylor
|
20,076
|
|
(14)
|
*
|
|
Anne Marie Whittemore
|
70,257
|
|
(15)
|
*
|
|
|
|
|
|
|
|
Directors and All Executive Officers as a Group (18 persons)
|
11,875,327
|
|
(16)
|
4.5%
|
|
(1)
|
Beneficial ownership of less than one percent is represented by an asterisk (*).
|
|
(2)
|
Includes
2,500
unvested restricted stock awards.
|
|
(3)
|
Includes
575,314
shares that may be acquired by Mr. Bernard within 60 days upon the exercise of stock options. Also includes (i)
279,463
shares held in a family trust and
60,500
shares held by a member of Mr. Bernard's family, and (ii)
939,842
shares held by trusts for which Mr. Bernard is a trustee and disclaims beneficial ownership. Neither he nor any member of his family has any economic interest in the trusts.
|
|
(4)
|
Includes
6,861
vested stock units that will be settled in shares of the Company's common stock upon Ms. Bush's separation from the Board.
|
|
(5)
|
Includes
12,186
shares that may be acquired by Mr. Hebb within 60 days upon the exercise of stock options,
2,500
unvested restricted stock awards, and
37,725
shares held in a family trust.
|
|
(6)
|
Includes
42,040
shares held by a member of Dr. Hrabowski's family. Also includes
4,377
vested stock units that will be settled in shares of the Company's common stock upon Dr. Hrabowski's separation from the Board.
|
|
(7)
|
Includes
1,322,799
shares held in trusts or by a limited liability company controlled by Mr. Kennedy. Also includes (i)
565,772
shares that may be acquired by Mr. Kennedy within 60 days upon the exercise of stock options, and (ii)
40,000
shares held by trusts for which Mr. Kennedy is a trustee and disclaims beneficial ownership. Neither he nor any member of his family has any economic interest in these trusts.
|
|
(8)
|
Includes
24,648
shares that may be acquired by Mr. MacLellan within 60 days upon the exercise of stock options and
4,464
vested stock units that will be settled in shares of the Company's common stock upon Mr. MacLellan's separation from the Board.
|
|
(9)
|
Includes
201,861
shares that may be acquired by Mr. Moreland within 60 days upon the exercise of stock options.
|
|
(10)
|
Includes
518,586
shares that may be acquired by Mr. Rogers within 60 days upon the exercise of stock options,
200,000
shares held by a member of Mr. Rogers' family, and
150,000
shares held in a family trust in which he disclaims beneficial ownership.
|
|
(11)
|
Includes
2,500
unvested restricted stock awards.
|
|
(12)
|
Includes
2,500
unvested restricted stock awards and
11,079
vested stock units that will be settled in shares of the Company's common stock upon Dr. Sommer's separation from the Board.
|
|
(13)
|
Includes
337,165
shares that may be acquired by Mr. Stromberg within 60 days upon the exercise of stock options and
96,000
shares held in trust for which Mr. Stromberg controls.
|
|
(14)
|
Includes
18,876
vested stock units that will be settled in shares of the Company's common stock upon Mr. Taylor's separation from the Board.
|
|
(15)
|
Includes
60,930
shares that may be acquired by Ms. Whittemore within 60 days upon the exercise of stock options and
2,605
vested stock units that will be settled in shares of the Company's common stock upon Ms. Whittemore's separation from the Board.
|
|
(16)
|
Includes
2,873,433
shares that may be acquired by all directors and executive officers as a group within 60 days upon the exercise of stock options,
23,974
unvested restricted stock awards held by certain directors and executive officers, and
48,262
stock units held by
six
of the non-employee directors that are vested and will be settled in shares of the Company's common stock upon their separation from the Board.
|
|
•
|
attracting and retaining talented and highly skilled management professionals with deep experience in investments and client service; and
|
|
•
|
maintaining a close commonality of interests between our management professionals and our stockholders by fostering a prudent approach to corporate performance and the control of risk in the enterprise, and linking their total compensation to our long-term success.
|
|
•
|
All of our independent directors serve on the Executive Compensation Committee, promoting full engagement by our Board of Directors on executive compensation matters. No management directors serve on the Executive Compensation Committee.
|
|
•
|
Our executive officers abide by significant stock ownership and retention requirements and maintain stock ownership levels well in excess of those requirements.
|
|
•
|
Our executive officers are prohibited from short sales involving company stock or hedging to offset a possible decrease in the market value of our stock held by them.
|
|
•
|
Our equity grant program for our NEOs includes restricted stock units that are subject to a performance-based vesting threshold with a twelve-month performance period.
|
|
•
|
We have a recoupment policy that applies to both cash incentive and equity awards to be considered in the event we make a material restatement of the Company's financial results (see page
33
).
|
|
•
|
None of our NEOs has an employment contract, severance, or change-in-control agreement.
|
|
•
|
Equity incentive awards granted under our 2012 Long-Term Incentive Plan provide for “double trigger” vesting acceleration in the event we are acquired or taken over by another company (see page
32
).
|
|
•
|
We do not have any supplemental retirement benefits.
|
|
•
|
We do not provide tax “gross-ups” to our executive officers, other than in the case of certain relocation expenses, consistent with our relocation policy.
|
|
•
|
Dividends on our performance-based equity awards are accrued during the performance period and only paid on those equity awards earned.
|
|
•
|
Our equity incentive plan prohibits the repricing or exchange of equity awards without stockholder approval.
|
|
•
|
We do not provide significant perquisites and other personal benefits to our executive officers.
|
|
•
|
Our Executive Compensation Committee has engaged an independent compensation consultant that has no other ties to the Company or its management.
|
|
•
|
We have in place a robust risk management program designed to identify, evaluate, and control risks, and our compensation and stock ownership programs work within this risk management system.
|
|
Affiliated Managers Group, Inc.
|
|
Eaton Vance Corp.
|
|
Invesco Ltd.
|
|
AllianceBernstein L.P.
|
|
Federated Investors, Inc.
|
|
Janus Capital Group, Inc.
|
|
BlackRock, Inc.
|
|
Franklin Resources, Inc.
|
|
Legg Mason, Inc.
|
|
Type of Compensation
|
Compensation Element
|
Purpose
|
|
Fixed Cash Base
|
Base Salaries
|
•
Provides competitive compensation to attract and retain diverse high-quality talent.
•
Intended to represent a minor portion of total compensation, so that the substantial majority of NEO compensation is dependent on incentive awards.
|
|
Incentive
|
Annual Cash Incentive
|
•
Motivates our NEOs and other senior management to achieve goals and objectives that are designed to be consistent with an overall strategy to manage the Company toward attainment of certain long-term objectives.
•
Provides competitive compensation to attract and retain diverse high-quality talent.
|
|
Long-term Equity Incentives
|
•
Aligns the long-term interests of our top managers and professionals, including our NEOs, with the long-term interest of our clients and stockholders by tying the value of awards to the future performance of our common stock.
•
Provides a significant incentive to our NEOs and other senior management to protect and enhance stockholder value.
•
Incentivizes our NEOs and other senior management to focus on long-term performance and profitability as the awards vest over approximately five years.
•
Provides competitive compensation to attract and retain diverse high quality talent.
•
Intended to represent a significant portion of the NEO's total compensation.
|
|
|
•
|
Produce superior long-term investment results for our clients;
|
|
•
|
Continue to deepen our professional investment staff and management;
|
|
•
|
Ensure that our core investment processes and capabilities continue to evolve to be successful at a larger scale, while managing capacity;
|
|
•
|
Sustain and enhance our diversified distribution strategy and capabilities, including targeting new opportunities for growth in the institutional and intermediary markets globally as well as growing individual and retirement plan assets;
|
|
•
|
Continue to make investments to enhance our organizational, systems, and risk management capabilities to effectively manage the increasing scope and complexity of our business in a global context;
|
|
•
|
Maintain our reputation for integrity, as well as our positive brand image and competitive name awareness;
|
|
•
|
Sustain our focus on enterprise-wide efforts to develop human talent and capabilities, to encourage a diverse and collaborative work force, and to plan for succession;
|
|
•
|
Monitor compensation practices and modify compensation and benefit plans as appropriate to attract, retain, and properly reward top talent; and
|
|
•
|
Manage our financial position and financial performance to balance short-term financial results with the need to continuously invest in long-term capabilities.
|
|
•
|
Our relative investment performance continued at a very favorable level with
74%
of our Price funds across their share classes outperforming their comparable Lipper averages on a total return basis for the three-year period ended
December 31, 2014
,
80%
outperforming for the five-year period,
88%
outperforming for the 10-year period, and
73%
outperforming for the one-year period. In addition, Morningstar awarded four or five stars to funds accounting for
82%
of our rated funds' assets under management. The performance of our institutional strategies against their benchmarks was substantially similar.
|
|
•
|
We continued to increase the size and quality of our investment team around the world and deepened the collaboration across that team. Specifically, we have increased the number of our investment professionals by
|
|
•
|
We continued to expand our investment offerings in
2014
both in terms of new strategies and new investment vehicles. We added three new equity and fixed-income products during
2014
. We also added two additional fixed-income products in January 2015.
|
|
•
|
We continued to distribute across multiple channels of distribution and continue to maintain strong client satisfaction levels. We have made good progress in our year-one execution of our plans to broaden and deepen the Company’s coverage globally. We made key hires globally, including sales and service professionals in Germany, Italy, and Spain and a Head of AsiaPac distribution in Singapore. We also continued to make investments in the infrastructure supporting the execution of these strategic initiatives.
|
|
•
|
We continued to make significant investments in our infrastructure, including new technology capabilities, digital and mobile capabilities, as well as data and risk management initiatives, to enhance our ability to perform for our clients and stockholders in the years to come. We expended
$126 million
in capital expenditures in
2014
, including
$103 million
in technology.
|
|
•
|
We continued to build learning programs that are focused on the development of our associates. We developed a comprehensive diversity and inclusion framework that we continue to expand upon.
|
|
•
|
Advisory revenues for the year were a record
$3.5 billion
, representing an increase of
14.6%
from
2013
, while operating expenses increased
13.2%
year-over-year, resulting in a higher operating margin in
2014
of
47.5%
. Return on equity of
24%
in
2014
is flat in relation to
2013
, but up from the average
22.5%
over the previous decade.
|
|
•
|
Our total assets under management finished the year at a record
$746.8 billion
, an increase of
$54.4 billion
, or
8%
, from the year ended
2013
. Market appreciation and net cash flows added
$50.7 billion
and
$3.7 billion
, respectively, in new assets during the year. Mutual fund net cash inflows of
$11.8 billion
were offset in part by net cash outflows from our other portfolios.
|
|
•
|
Our overall financial condition remained very strong, as we finished the year with
$5.4 billion
of stockholders' equity,
$3.4 billion
of cash and sponsored portfolio fund holdings, and no debt. We increased the regular annual dividend payout to our stockholders in
2014
for the
28th
consecutive year by nearly
16%
and spent
$416 million
to repurchase
5.3 million
shares of our common stock at an average price of
$78.20
per share.
|
|
Name
|
|
Maximum Percentage of Total Pool
|
|
Maximum Payout Based on Total Pool
|
|
Actual Percentage of Total Pool
|
|
2014
Payout
|
|
Percentage Increase over 2013 Payout
|
||||
|
James A.C. Kennedy
|
|
15%
|
|
$
|
23,887,200
|
|
|
4.4%
|
|
$
|
7,000,000
|
|
|
8%
|
|
Brian C. Rogers
|
|
15%
|
|
$
|
23,887,200
|
|
|
4.2%
|
|
$
|
6,700,000
|
|
|
1%
|
|
Edward C. Bernard
|
|
14%
|
|
$
|
22,294,720
|
|
|
3.8%
|
|
$
|
6,000,000
|
|
|
11%
|
|
William J. Stromberg
|
|
14%
|
|
$
|
22,294,720
|
|
|
3.8%
|
|
$
|
6,100,000
|
|
|
9%
|
|
Kenneth V. Moreland
|
|
5%
|
|
$
|
7,962,400
|
|
|
.6%
|
|
$
|
900,000
|
|
|
16%
|
|
Name
|
|
ECC Considerations
|
|
James A.C. Kennedy
|
|
•
Joint leadership and responsibility with Messrs. Rogers and Bernard for the overall management, direction, and performance of the Company.
•
Leadership, responsibility, and performance as our chief executive officer and president.
•
Leadership and responsibility for the performance of those functions that are direct reports, including Investments, Trading, Human Resources, and Finance.
•
Leadership, responsibility, and performance as Chairman of our Management Committee and Management Compensation Committee.
|
|
Brian C. Rogers
|
|
•
Joint leadership and responsibility with Messrs. Kennedy and Bernard for the overall management, direction, and performance of the Company.
•
Leadership, responsibility, and performance as chair of the Price Group Board.
•
Performance as Chief Investment Officer, including the broad-based investment leadership he provides.
•
Performance managing nearly $46 billion in client assets.
|
|
Edward C. Bernard
|
|
•
Joint leadership and responsibility with Messrs. Kennedy and Rogers for the overall management, direction, and performance of the Company.
•
Leadership, responsibility, and performance as head of the Company’s marketing, distribution, operations, technology, and legal functions.
•
Leadership as chair of the sponsored mutual funds’ board.
|
|
William J. Stromberg
|
|
•
Leadership, responsibility, and performance as head of Global Equity and Global Equity Research.
•
Responsibility and performance as a member of the Management Committee, Management Compensation Committee, and Finance Committee.
•
Strong investment performance results relative to industry benchmarks.
|
|
Kenneth V. Moreland
|
|
•
Leadership, responsibility, and performance as chief financial officer and treasurer, including his direct responsibility as chair of the Finance Committee and for all of our reporting and financial management matters.
•
Responsibility for other business management operations of the Company, including enterprise risk and facilities management functions.
|
|
Name
|
Options
|
Performance-Based Restricted Stock Units
|
Total Awards Granted
|
|
||
|
James A.C. Kennedy
|
32,500
|
|
9,750
|
|
42,250
|
|
|
Brian C. Rogers
|
32,500
|
|
9,750
|
|
42,250
|
|
|
Edward C. Bernard
|
32,500
|
|
9,750
|
|
42,250
|
|
|
William J. Stromberg
|
35,000
|
|
10,500
|
|
45,500
|
|
|
Kenneth V. Moreland
|
11,500
|
|
3,450
|
|
14,950
|
|
|
Total Granted to NEOs
|
144,000
|
|
43,200
|
|
187,200
|
|
|
Name
|
ECC Considerations
|
|
James A.C. Kennedy,
Brian C. Rogers, and
Edward C. Bernard
|
•
Performance in the most senior management roles of the Company.
•
Leadership over increasing global corporate responsibilities.
•
Contributions to the Company’s strong relative performance.
•
Common stock holdings accumulated over time.
|
|
William J. Stromberg
|
•
Strong leadership in expanding the Company’s global equity investment capabilities.
•
Strong investment performance results relative to industry benchmarks.
•
Contributions to helping the Company meet its goals and objectives as a member of the Management Committee.
•
Common stock holdings accumulated over time.
|
|
Kenneth V. Moreland
|
•
Management responsibilities for financial and other business management operations of the Company.
•
Contributions in helping the Company meet its goals and objectives as CFO and as chairman of the Finance Committee.
|
|
TROW Operating Margin as Percent of Industry Average Margin
|
>=100%
|
90%-99%
|
80%-89%
|
70%-79%
|
60%-69%
|
50%-59%
|
< 50%
|
|
Amount of Restricted Stock Units Eligible to be Earned
(1)
|
100%
|
90%
|
80%
|
70%
|
60%
|
50%
|
0%
|
|
(1)
|
Performance-based awards that are eligible to be earned are also subject to the standard time-based vesting schedule for 2014 awards granted under our annual award program.
|
|
Grant Date
|
Performance Period
|
TROW Operating Margin as Percent of Industry Average Margin
|
Amount Earned and Subject to Standard Vesting Schedule
|
|
September, 2013
|
July 1, 2013 to June 30, 2014
|
Greater than 100%
|
100% granted
|
|
February, 2014
|
January 1, 2014 to December 31, 2014
|
Greater than 100%
|
100% granted
|
|
September, 2014
|
July 1, 2014 to June 30, 2015
|
Undeterminable at this time
|
|
|
Dwight S. Taylor, Chairman
|
|
Mark S. Bartlett
|
|
Mary K. Bush
|
|
Donald B. Hebb, Jr.
|
|
Dr. Freeman A. Hrabowski, III
|
|
Robert F. MacLellan
|
|
Olympia J. Snowe
|
|
Dr. Alfred Sommer
|
|
Anne Marie Whittemore
|
|
Name and Principal Position
|
Year
|
Salary
|
Stock Awards
(2)
|
Option Awards
(3)
|
Non-Equity Incentive Plan Compensation
(4)
|
All Other Compensation
(5)
|
Total
|
||||||||||||
|
James A.C. Kennedy
|
2014
|
$
|
350,000
|
|
$
|
781,223
|
|
$
|
689,575
|
|
$
|
7,000,000
|
|
$
|
81,350
|
|
$
|
8,902,148
|
|
|
Chief Executive Officer and President
|
2013
|
$
|
350,000
|
|
$
|
827,810
|
|
$
|
754,085
|
|
$
|
6,500,000
|
|
$
|
70,022
|
|
$
|
8,501,917
|
|
|
2012
|
$
|
350,000
|
|
$
|
888,383
|
|
$
|
982,207
|
|
$
|
6,100,000
|
|
$
|
115,911
|
|
$
|
8,436,501
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||
|
Brian C. Rogers
|
2014
|
$
|
350,000
|
|
$
|
781,223
|
|
$
|
689,575
|
|
$
|
6,700,000
|
|
$
|
77,080
|
|
$
|
8,597,878
|
|
|
Chairman and Chief Investment Officer
|
2013
|
$
|
350,000
|
|
$
|
827,810
|
|
$
|
754,085
|
|
$
|
6,650,000
|
|
$
|
69,004
|
|
$
|
8,650,899
|
|
|
2012
|
$
|
350,000
|
|
$
|
888,383
|
|
$
|
795,533
|
|
$
|
6,100,000
|
|
$
|
193,601
|
|
$
|
8,327,517
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||
|
Edward C. Bernard
|
2014
|
$
|
350,000
|
|
$
|
781,223
|
|
$
|
689,575
|
|
$
|
6,000,000
|
|
$
|
79,682
|
|
$
|
7,900,480
|
|
|
Vice Chairman
|
2013
|
$
|
350,000
|
|
$
|
827,810
|
|
$
|
754,085
|
|
$
|
5,400,000
|
|
$
|
72,481
|
|
$
|
7,404,376
|
|
|
2012
|
$
|
350,000
|
|
$
|
888,383
|
|
$
|
795,533
|
|
$
|
5,400,000
|
|
$
|
72,601
|
|
$
|
7,506,517
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||
|
William J. Stromberg
|
2014
|
$
|
350,000
|
|
$
|
841,523
|
|
$
|
739,935
|
|
$
|
6,100,000
|
|
$
|
79,301
|
|
$
|
8,110,759
|
|
|
Head of Equity
|
2013
|
$
|
350,000
|
|
$
|
860,700
|
|
$
|
785,680
|
|
$
|
5,600,000
|
|
$
|
71,991
|
|
$
|
7,668,371
|
|
|
2012
|
$
|
350,000
|
|
$
|
771,739
|
|
$
|
690,823
|
|
$
|
5,250,000
|
|
$
|
72,628
|
|
$
|
7,135,190
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||
|
Kenneth V. Moreland
|
2014
|
$
|
350,000
|
|
$
|
276,500
|
|
$
|
243,122
|
|
$
|
900,000
|
|
$
|
78,194
|
|
$
|
1,847,816
|
|
|
Chief Financial Officer and Treasurer
|
2013
|
$
|
350,000
|
|
$
|
258,210
|
|
$
|
235,704
|
|
$
|
775,000
|
|
$
|
72,150
|
|
$
|
1,691,064
|
|
|
2012
|
$
|
350,000
|
|
$
|
233,963
|
|
$
|
209,298
|
|
$
|
675,000
|
|
$
|
71,857
|
|
$
|
1,540,118
|
|
|
|
(1)
|
Includes only those columns relating to compensation awarded to, earned by, or paid to the NEOs in
2014
,
2013
, and
2012
. All other columns have been omitted.
|
|
(2)
|
Represents the full grant date fair value of performance-based restricted stock units granted. The fair value was computed using the market price per share of T. Rowe Price common stock on the date of grant multiplied by the target number of units, as this was considered the probable outcome. See the Grants of Plan-Based Awards Table for the target number of units.
|
|
(3)
|
Represents the full grant date fair value computed using the Black-Scholes option-pricing model. A description of the assumptions used for volatility, risk-free interest rate, dividend yield, and expected life in the option-pricing model is included in the Significant Accounting Policies for Stock-Based Compensation on page
36
of the
2014
Annual Report to Stockholders.
|
|
(4)
|
Represents cash amounts awarded by the Executive Compensation Committee and paid to NEOs under the
2014
Annual Incentive Compensation Pool. See our Compensation Discussion and Analysis and the Grants of Plan-Based Awards Table for more details of the workings of this plan.
|
|
(5)
|
The following types of compensation are included in the "All Other Compensation" column for
2014
:
|
|
Name
|
Contributions
to Retirement
Program
|
|
Retirement Program Limit Bonus
(a)
|
Matching Contributions to Stock Purchase Plan
(b)
|
Matching Gifts to Charitable Organizations
(c)
|
Perquisites and Other Personal Benefits
(d)
|
Total
|
|||||||||||
|
James A.C. Kennedy
|
$
|
34,500
|
|
$
|
4,613
|
|
$
|
—
|
|
$
|
25,000
|
|
$
|
17,237
|
|
$
|
81,350
|
|
|
Brian C. Rogers
|
$
|
34,500
|
|
$
|
4,613
|
|
$
|
—
|
|
$
|
25,000
|
|
$
|
12,967
|
|
$
|
77,080
|
|
|
Edward C. Bernard
|
$
|
34,500
|
|
$
|
4,613
|
|
$
|
4,000
|
|
$
|
25,000
|
|
$
|
11,569
|
|
$
|
79,682
|
|
|
William J. Stromberg
|
$
|
34,500
|
|
$
|
4,613
|
|
$
|
4,000
|
|
$
|
25,000
|
|
$
|
11,188
|
|
$
|
79,301
|
|
|
Kenneth V. Moreland
|
$
|
34,500
|
|
$
|
4,613
|
|
$
|
4,000
|
|
$
|
25,000
|
|
$
|
10,081
|
|
$
|
78,194
|
|
|
(a)
|
Cash compensation for the amount calculated under the U.S. Retirement Program that could not be credited to their retirement accounts in
2014
due to the contribution limits imposed under Section 415 of the Internal Revenue Code.
|
|
(b)
|
Matching contributions paid under our Employee Stock Purchase Plan offered to all employees of Price Group and its subsidiaries.
|
|
(c)
|
NEOs, directors, and all employees of Price Group and its subsidiaries are eligible to have personal gifts up to an annual limit to qualified charitable organizations matched by our sponsored T. Rowe Price Foundation, in the case of U.S. employees and Price Group in the case of employees outside the U.S. For
2014
, all of the NEOs were eligible to have up to
$25,000
matched by the Foundation.
|
|
(d)
|
Costs incurred by Price Group under programs available to all senior officers, including the NEO's, for executive health benefits and parking, as well as certain costs covered by Price Group relating to certain travel upgrades and spousal participation in events held in connection with the Price Group and Price funds annual joint Board of Directors meeting as well as other business-related functions.
|
|
|
Grant Date
|
|
Date of Executive Compensation Committee Meeting at which Grant was Approved
|
Estimated Possible
Payouts under
Non-Equity Incentive
Plan Awards
(2)
|
Estimated Possible Payouts under Equity Incentive Plan Awards
|
Number of Securities Underlying Options
|
Exercise Price of Option Awards per Share
|
Grant Date Fair Value of Stock and Option Awards
(3)
|
|||||||||||
|
Name
|
|
Threshold ($)
|
Maximum ($)
|
Target (#)
|
Maximum (#)
|
||||||||||||||
|
James A.C. Kennedy
|
2/18/2014
|
(2)
|
|
$—
|
$
|
23,887,200
|
|
|
|
|
|
|
|||||||
|
|
2/19/2014
|
(4)
|
2/18/2014
|
|
|
5,250
|
|
5,250
|
|
|
|
$
|
419,423
|
|
|||||
|
|
2/19/2014
|
(5)
|
2/18/2014
|
|
|
|
|
|
|
17,500
|
|
$
|
79.89
|
|
$
|
387,415
|
|
||
|
|
9/9/2014
|
(4)
|
9/8/2014
|
|
|
4,500
|
|
4,500
|
|
|
|
$
|
361,800
|
|
|||||
|
|
9/9/2014
|
(5)
|
9/8/2014
|
|
|
|
|
15,000
|
|
$
|
80.40
|
|
$
|
302,160
|
|
||||
|
Brian C. Rogers
|
2/18/2014
|
(2)
|
|
$—
|
$
|
23,887,200
|
|
|
|
|
|
|
|||||||
|
|
2/19/2014
|
(4)
|
2/18/2014
|
|
|
5,250
|
|
5,250
|
|
|
|
$
|
419,423
|
|
|||||
|
|
2/19/2014
|
(5)
|
2/18/2014
|
|
|
|
|
17,500
|
|
$
|
79.89
|
|
$
|
387,415
|
|
||||
|
|
9/9/2014
|
(4)
|
9/8/2014
|
|
|
4,500
|
|
4,500
|
|
|
|
$
|
361,800
|
|
|||||
|
|
9/9/2014
|
(5)
|
9/8/2014
|
|
|
|
|
15,000
|
|
$
|
80.40
|
|
$
|
302,160
|
|
||||
|
Edward C. Bernard
|
2/18/2014
|
(2)
|
|
$—
|
$
|
22,294,720
|
|
|
|
|
|
|
|||||||
|
|
2/19/2014
|
(4)
|
2/18/2014
|
|
|
5,250
|
|
5,250
|
|
|
|
$
|
419,423
|
|
|||||
|
|
2/19/2014
|
(5)
|
2/18/2014
|
|
|
|
|
17,500
|
|
$
|
79.89
|
|
$
|
387,415
|
|
||||
|
|
9/9/2014
|
(4)
|
9/8/2014
|
|
|
4,500
|
|
4,500
|
|
|
|
$
|
361,800
|
|
|||||
|
|
9/9/2014
|
(5)
|
9/8/2014
|
|
|
|
|
15,000
|
|
$
|
80.40
|
|
$
|
302,160
|
|
||||
|
|
Grant Date
|
|
Date of Executive Compensation Committee Meeting at which Grant was Approved
|
Estimated Possible
Payouts under
Non-Equity Incentive
Plan Awards
(2)
|
Estimated Possible Payouts under Equity Incentive Plan Awards
|
Number of Securities Underlying Options
|
Exercise Price of Option Awards per Share
|
Grant Date Fair Value of Stock and Option Awards
(3)
|
|||||||||||
|
Name
|
|
Threshold ($)
|
Maximum ($)
|
Target (#)
|
Maximum (#)
|
||||||||||||||
|
William J. Stromberg
|
2/18/2014
|
(2)
|
|
$—
|
$
|
22,294,720
|
|
|
|
|
|
|
|||||||
|
|
2/19/2014
|
(4)
|
2/18/2014
|
|
|
5,250
|
|
5,250
|
|
|
|
$
|
419,423
|
|
|||||
|
|
2/19/2014
|
(5)
|
2/18/2014
|
|
|
|
|
17,500
|
|
$
|
79.89
|
|
$
|
387,415
|
|
||||
|
|
9/9/2014
|
(4)
|
9/8/2014
|
|
|
5,250
|
|
5,250
|
|
|
|
$
|
422,100
|
|
|||||
|
|
9/9/2014
|
(5)
|
9/8/2014
|
|
|
|
|
17,500
|
|
$
|
80.40
|
|
$
|
352,520
|
|
||||
|
Kenneth V. Moreland
|
2/18/2014
|
(2)
|
|
$—
|
$
|
7,962,400
|
|
|
|
|
|
|
|||||||
|
|
2/19/2014
|
(4)
|
2/18/2014
|
|
|
1,725
|
|
1,725
|
|
|
|
$
|
137,810
|
|
|||||
|
|
2/19/2014
|
(5)
|
2/18/2014
|
|
|
|
|
5,750
|
|
$
|
79.89
|
|
$
|
127,294
|
|
||||
|
|
9/9/2014
|
(4)
|
9/8/2014
|
|
|
1,725
|
|
1,725
|
|
|
|
$
|
138,690
|
|
|||||
|
|
9/9/2014
|
(5)
|
9/8/2014
|
|
|
|
|
5,750
|
|
$
|
80.40
|
|
$
|
115,828
|
|
||||
|
(1)
|
Includes only those columns relating to plan-based awards granted during
2014
. All other columns have been omitted.
|
|
(2)
|
The maximum represents the highest possible amount that could have been paid to each of these individuals under the
2014
Annual Incentive Compensation Pool based on our
2014
audited financial statements. The Executive Compensation Committee has discretion to award no bonus under this program, or to award up to the maximum bonus. As a result, there is no minimum amount payable even if performance goals are met. For
2014
, the Executive Compensation Committee awarded significantly less than the maximum amount to the NEOs and the actual amount awarded has been disclosed in the Summary Compensation Table on page
34
under “Non-Equity Incentive Plan Compensation.” See our Compensation Discussion and Analysis for the workings of the Annual Incentive Compensation Pool.
|
|
(3)
|
Represents the grant date fair value of the performance-based restricted stock units and options granted in
2014
. The grant date fair value of the performance-based restricted stock units was measured using the market price per share of T. Rowe Price common stock on the date of grant multiplied by the target number of units noted in the table, as this was considered the probable outcome. The grant date fair value for options granted in
2014
was estimated using the Black-Scholes option-pricing model. A description of the assumptions used for volatility, risk-free interest rate, dividend yield, and expected life in the option-pricing model is included in Significant Accounting Policies for Stock-Based Compensation on page
36
of the
2014
Annual Report to Stockholders.
|
|
(4)
|
Represents performance-based restricted stock units granted as part of the Company's annual equity incentive program from its 2012 Long-Term Incentive Plan (2012 Plan). These performance-based restricted stock units are subject to a performance-based vesting threshold with a twelve-month performance period. The performance period for the February
2014
grant ran from January 1,
2014
to December 31,
2014
, and the performance period for the September
2014
grant runs from July 1,
2014
to June 30,
2015
. For each grant, the target payout represents the number of restricted stock units to be earned by the NEO if the Company's operating margin for the performance period is at least 100% of the average operating margin of a designated peer group. The Company's operating margin performance below this target threshold results in forfeiture of some or all of the restricted stock units. The number of restricted stock units earned by the NEO following the performance period is also subject to time-based vesting before they are settled in shares of our common stock. Vesting occurs 20% on each of
12/10/2015
,
12/09/2016
,
12/08/2017
,
12/10/2018
, and
12/10/2019
. These grant agreements include a provision that allows for continued vesting for a period of 36 months from the date of termination if certain age and service criteria are met. Dividends on these performance-based restricted stock units are accrued during the performance period and are only paid on those units earned. Additional information related to these performance-based restricted stock units, including a listing of companies in the designated peer group, are included in our Compensation Discussion and Analysis beginning on page
20
.
|
|
(5)
|
Represent options granted as part of the Company's annual equity incentive program from its 2012 Plan. Vesting of these options is time-based and occurs at a rate of 20% per year on
12/10/2015
,
12/09/2016
,
12/08/2017
,
12/10/2018
, and
12/10/2019
. These grant agreements include a provision that allows for continued vesting for a period of 36 months from the date of termination if certain age and service criteria are met.
|
|
|
Option Awards
|
|
Stock Awards
|
|
|||||||||||||||||||
|
Name
|
Number of Securities Underlying Unexercised Options: Exercisable
|
|
Number of Securities Underlying Unexercised Options: Unexercisable
|
|
Option Exercise Price
|
Option Expiration Date
|
|
Number of Units of Stock That Have Not Vested (#)
|
|
Market Value of Units of Stock That Have Not Vested ($)
|
|
Equity Incentive Plan Awards: Number of Unearned Units That Have Not Vested (#)
|
|
Equity Incentive Plan Awards: Market Value of Unearned Units That Have Not Vested ($)
|
|
||||||||
|
James A.C. Kennedy
|
99,251
|
|
|
|
|
$
|
45.479
|
|
11/1/2016
|
|
|
|
|
|
|
|
|
|
|||||
|
99,572
|
|
|
|
|
$
|
49.250
|
|
9/6/2017
|
|
|
|
|
|
|
|
|
|
||||||
|
99,802
|
|
|
|
|
$
|
56.202
|
|
9/4/2018
|
|
|
|
|
|
|
|
|
|
||||||
|
|
47,186
|
|
|
|
|
$
|
27.047
|
|
2/12/2019
|
|
|
|
|
|
|
|
|
|
|||||
|
|
50,780
|
|
|
|
|
$
|
44.455
|
|
9/10/2019
|
|
|
|
|
|
|
|
|
|
|||||
|
|
40,625
|
|
|
10,155
|
|
(2)
|
$
|
48.837
|
|
2/18/2020
|
|
|
|
|
|
|
|
|
|
||||
|
|
40,624
|
|
|
10,157
|
|
(2)
|
$
|
46.937
|
|
9/8/2020
|
|
|
|
|
|
|
|
|
|
||||
|
|
30,468
|
|
|
20,313
|
|
(3)
|
$
|
69.248
|
|
2/17/2021
|
|
|
|
|
|
|
|
|
|
||||
|
|
30,468
|
|
|
20,313
|
|
(3)
|
$
|
49.772
|
|
9/8/2021
|
|
|
|
|
|
|
|
|
|
||||
|
|
10,156
|
|
|
15,234
|
|
(4)
|
$
|
60.544
|
|
2/23/2022
|
|
|
|
|
|
|
|
|
|
||||
|
|
9,140
|
|
|
13,711
|
|
(4)
|
$
|
62.316
|
|
9/6/2022
|
|
|
|
|
|
|
|
|
|
||||
|
|
4,500
|
|
|
18,000
|
|
(5)
|
$
|
71.410
|
|
2/21/2023
|
|
|
|
|
|
|
|
|
|
||||
|
|
3,200
|
|
|
12,800
|
|
(5)
|
$
|
72.040
|
|
9/10/2023
|
|
|
|
|
|
|
|
|
|
||||
|
|
—
|
|
|
17,500
|
|
(6)
|
$
|
79.890
|
|
2/19/2024
|
|
|
|
|
|
|
|
|
|
||||
|
|
—
|
|
|
15,000
|
|
(6)
|
$
|
80.400
|
|
9/9/2024
|
|
|
|
|
|
|
|
|
|
||||
|
|
|
|
|
|
|
|
|
4,500
|
|
(7)
|
386,370
|
|
(7)
|
|
|
|
|
||||||
|
|
|
|
|
|
|
|
|
4,050
|
|
(8)
|
347,733
|
|
(8)
|
|
|
|
|
||||||
|
|
|
|
|
|
|
|
|
5,400
|
|
(9)
|
463,644
|
|
(9)
|
|
|
|
|
||||||
|
|
|
|
|
|
|
|
|
3,840
|
|
(10)
|
329,702
|
|
(10)
|
|
|
|
|
||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
5,250
|
|
(11)
|
450,765
|
|
(11)
|
||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
4,500
|
|
(12)
|
386,370
|
|
(12)
|
||||||
|
Brian C. Rogers
|
99,251
|
|
|
|
|
$
|
45.479
|
|
11/1/2016
|
|
|
|
|
|
|
|
|
|
|||||
|
99,572
|
|
|
|
|
$
|
49.250
|
|
9/6/2017
|
|
|
|
|
|
|
|
|
|
||||||
|
|
99,802
|
|
|
|
|
$
|
56.202
|
|
9/4/2018
|
|
|
|
|
|
|
|
|
|
|||||
|
|
50,780
|
|
|
|
|
$
|
44.455
|
|
9/10/2019
|
|
|
|
|
|
|
|
|
|
|||||
|
|
40,625
|
|
|
10,155
|
|
(2)
|
$
|
48.837
|
|
2/18/2020
|
|
|
|
|
|
|
|
|
|
||||
|
|
40,624
|
|
|
10,157
|
|
(2)
|
$
|
46.937
|
|
9/8/2020
|
|
|
|
|
|
|
|
|
|
||||
|
|
30,468
|
|
|
20,313
|
|
(3)
|
$
|
69.248
|
|
2/17/2021
|
|
|
|
|
|
|
|
|
|
||||
|
|
30,468
|
|
|
20,313
|
|
(3)
|
$
|
49.772
|
|
9/8/2021
|
|
|
|
|
|
|
|
|
|
||||
|
|
10,156
|
|
|
15,234
|
|
(4)
|
$
|
60.544
|
|
2/23/2022
|
|
|
|
|
|
|
|
|
|
||||
|
|
9,140
|
|
|
13,711
|
|
(4)
|
$
|
62.316
|
|
9/6/2022
|
|
|
|
|
|
|
|
|
|
||||
|
|
4,500
|
|
|
18,000
|
|
(5)
|
$
|
71.410
|
|
2/21/2023
|
|
|
|
|
|
|
|
|
|
||||
|
|
3,200
|
|
|
12,800
|
|
(5)
|
$
|
72.040
|
|
9/10/2023
|
|
|
|
|
|
|
|
|
|
||||
|
|
—
|
|
|
17,500
|
|
(6)
|
$
|
79.890
|
|
2/19/2024
|
|
|
|
|
|
|
|
|
|
||||
|
|
—
|
|
|
15,000
|
|
(6)
|
$
|
80.400
|
|
9/9/2024
|
|
|
|
|
|
|
|
|
|
||||
|
|
|
|
|
|
|
|
|
4,500
|
|
(7)
|
386,370
|
|
(7)
|
|
|
|
|
||||||
|
|
Option Awards
|
|
Stock Awards
|
|
|||||||||||||||||||
|
Name
|
Number of Securities Underlying Unexercised Options: Exercisable
|
|
Number of Securities Underlying Unexercised Options: Unexercisable
|
|
Option Exercise Price
|
Option Expiration Date
|
|
Number of Units of Stock That Have Not Vested (#)
|
|
Market Value of Units of Stock That Have Not Vested ($)
|
|
Equity Incentive Plan Awards: Number of Unearned Units That Have Not Vested (#)
|
|
Equity Incentive Plan Awards: Market Value of Unearned Units That Have Not Vested ($)
|
|
||||||||
|
Brian C. Rogers
|
|
|
|
|
|
|
|
4,050
|
|
(8)
|
347,733
|
|
(8)
|
|
|
|
|
||||||
|
|
|
|
|
|
|
|
5,400
|
|
(9)
|
463,644
|
|
(9)
|
|
|
|
|
|||||||
|
|
|
|
|
|
|
|
|
3,840
|
|
(10)
|
329,702
|
|
(10)
|
|
|
|
|
||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
5,250
|
|
(11)
|
450,765
|
|
(11)
|
||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
4,500
|
|
(12)
|
386,370
|
|
(12)
|
||||||
|
Edward C. Bernard
|
101,448
|
|
|
|
|
$
|
45.479
|
|
11/1/2016
|
|
|
|
|
|
|
|
|
|
|||||
|
101,562
|
|
|
|
|
$
|
49.250
|
|
9/6/2017
|
|
|
|
|
|
|
|
|
|
||||||
|
|
101,562
|
|
|
|
|
$
|
56.202
|
|
9/4/2018
|
|
|
|
|
|
|
|
|
|
|||||
|
|
50,781
|
|
|
|
|
$
|
27.047
|
|
2/12/2019
|
|
|
|
|
|
|
|
|
|
|||||
|
|
50,780
|
|
|
|
|
$
|
44.455
|
|
9/10/2019
|
|
|
|
|
|
|
|
|
|
|||||
|
|
40,625
|
|
|
10,155
|
|
(2)
|
$
|
48.837
|
|
2/18/2020
|
|
|
|
|
|
|
|
|
|
||||
|
|
40,624
|
|
|
10,157
|
|
(2)
|
$
|
46.937
|
|
9/8/2020
|
|
|
|
|
|
|
|
|
|
||||
|
|
30,468
|
|
|
20,313
|
|
(3)
|
$
|
69.248
|
|
2/17/2021
|
|
|
|
|
|
|
|
|
|
||||
|
|
30,468
|
|
|
20,313
|
|
(3)
|
$
|
49.772
|
|
9/8/2021
|
|
|
|
|
|
|
|
|
|
||||
|
|
10,156
|
|
|
15,234
|
|
(4)
|
$
|
60.544
|
|
2/23/2022
|
|
|
|
|
|
|
|
|
|
||||
|
|
9,140
|
|
|
13,711
|
|
(4)
|
$
|
62.316
|
|
9/6/2022
|
|
|
|
|
|
|
|
|
|
||||
|
|
4,500
|
|
|
18,000
|
|
(5)
|
$
|
71.410
|
|
2/21/2023
|
|
|
|
|
|
|
|
|
|
||||
|
|
3,200
|
|
|
12,800
|
|
(5)
|
$
|
72.040
|
|
9/10/2023
|
|
|
|
|
|
|
|
|
|
||||
|
|
—
|
|
|
17,500
|
|
(6)
|
$
|
79.890
|
|
2/19/2024
|
|
|
|
|
|
|
|
|
|
||||
|
|
—
|
|
|
15,000
|
|
(6)
|
$
|
80.400
|
|
9/9/2024
|
|
|
|
|
|
|
|
|
|
||||
|
|
|
|
|
|
|
|
|
4,500
|
|
(7)
|
386,370
|
|
(7)
|
|
|
|
|
||||||
|
|
|
|
|
|
|
|
|
4,050
|
|
(8)
|
347,733
|
|
(8)
|
|
|
|
|
||||||
|
|
|
|
|
|
|
|
|
5,400
|
|
(9)
|
463,644
|
|
(9)
|
|
|
|
|
||||||
|
|
|
|
|
|
|
|
|
3,840
|
|
(10)
|
329,702
|
|
(10)
|
|
|
|
|
||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
5,250
|
|
(11)
|
450,765
|
|
(11)
|
||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
4,500
|
|
(12)
|
386,370
|
|
(12)
|
||||||
|
William J. Stromberg
|
89,646
|
|
|
|
|
$
|
56.202
|
|
9/4/2018
|
|
|
|
|
|
|
|
|
|
|||||
|
47,186
|
|
|
|
|
$
|
27.047
|
|
2/12/2019
|
|
|
|
|
|
|
|
|
|
||||||
|
|
50,657
|
|
|
|
|
$
|
44.455
|
|
9/10/2019
|
|
|
|
|
|
|
|
|
|
|||||
|
|
36,562
|
|
|
9,140
|
|
(2)
|
$
|
48.837
|
|
2/18/2020
|
|
|
|
|
|
|
|
|
|
||||
|
|
36,562
|
|
|
9,141
|
|
(2)
|
$
|
46.937
|
|
9/8/2020
|
|
|
|
|
|
|
|
|
|
||||
|
|
25,898
|
|
|
17,265
|
|
(3)
|
$
|
69.248
|
|
2/17/2021
|
|
|
|
|
|
|
|
|
|
||||
|
|
25,898
|
|
|
17,266
|
|
(3)
|
$
|
49.772
|
|
9/8/2021
|
|
|
|
|
|
|
|
|
|
||||
|
|
8,632
|
|
|
12,949
|
|
(4)
|
$
|
60.544
|
|
2/23/2022
|
|
|
|
|
|
|
|
|
|
||||
|
|
8,124
|
|
|
12,188
|
|
(4)
|
$
|
62.316
|
|
9/6/2022
|
|
|
|
|
|
|
|
|
|
||||
|
|
4,000
|
|
|
16,000
|
|
(5)
|
$
|
71.410
|
|
2/21/2023
|
|
|
|
|
|
|
|
|
|
||||
|
|
4,000
|
|
|
16,000
|
|
(5)
|
$
|
72.040
|
|
9/10/2023
|
|
|
|
|
|
|
|
|
|
||||
|
|
—
|
|
|
17,500
|
|
(6)
|
$
|
79.890
|
|
2/19/2024
|
|
|
|
|
|
|
|
|
|
||||
|
|
—
|
|
|
17,500
|
|
(6)
|
$
|
80.400
|
|
9/9/2024
|
|
|
|
|
|
|
|
|
|
||||
|
|
|
|
|
|
|
|
|
3,825
|
|
(7)
|
328,415
|
|
(7)
|
|
|
|
|
||||||
|
|
Option Awards
|
|
Stock Awards
|
|
|||||||||||||||||||
|
Name
|
Number of Securities Underlying Unexercised Options: Exercisable
|
|
Number of Securities Underlying Unexercised Options: Unexercisable
|
|
Option Exercise Price
|
Option Expiration Date
|
|
Number of Units of Stock That Have Not Vested (#)
|
|
Market Value of Units of Stock That Have Not Vested ($)
|
|
Equity Incentive Plan Awards: Number of Unearned Units That Have Not Vested (#)
|
|
Equity Incentive Plan Awards: Market Value of Unearned Units That Have Not Vested ($)
|
|
||||||||
|
William J. Stromberg
|
|
|
|
|
|
|
|
3,600
|
|
(8)
|
309,096
|
|
(8)
|
|
|
|
|
||||||
|
|
|
|
|
|
|
|
4,800
|
|
(9)
|
412,128
|
|
(9)
|
|
|
|
|
|||||||
|
|
|
|
|
|
|
|
|
4,800
|
|
(10)
|
412,128
|
|
(10)
|
|
|
|
|
||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
5,250
|
|
(11)
|
450,765
|
|
(11)
|
||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
5,250
|
|
(12)
|
450,765
|
|
(12)
|
||||||
|
Kenneth V. Moreland
|
3,046
|
|
|
|
|
$
|
32.118
|
|
10/3/2015
|
|
|
|
|
|
|
|
|
|
|||||
|
40,624
|
|
|
|
|
$
|
45.479
|
|
11/1/2016
|
|
|
|
|
|
|
|
|
|
||||||
|
40,624
|
|
|
|
|
$
|
49.250
|
|
9/6/2017
|
|
|
|
|
|
|
|
|
|
||||||
|
|
35,546
|
|
|
|
|
$
|
56.202
|
|
9/4/2018
|
|
|
|
|
|
|
|
|
|
|||||
|
|
18,280
|
|
|
|
|
$
|
27.047
|
|
2/12/2019
|
|
|
|
|
|
|
|
|
|
|||||
|
|
18,280
|
|
|
|
|
$
|
44.455
|
|
9/10/2019
|
|
|
|
|
|
|
|
|
|
|||||
|
|
11,375
|
|
|
2,843
|
|
(2)
|
$
|
48.837
|
|
2/18/2020
|
|
|
|
|
|
|
|
|
|
||||
|
|
11,374
|
|
|
2,844
|
|
(2)
|
$
|
46.937
|
|
9/8/2020
|
|
|
|
|
|
|
|
|
|
||||
|
|
7,617
|
|
|
5,078
|
|
(3)
|
$
|
69.248
|
|
2/17/2021
|
|
|
|
|
|
|
|
|
|
||||
|
|
7,617
|
|
|
5,078
|
|
(3)
|
$
|
49.772
|
|
9/8/2021
|
|
|
|
|
|
|
|
|
|
||||
|
|
2,539
|
|
|
3,808
|
|
(4)
|
$
|
60.544
|
|
2/23/2022
|
|
|
|
|
|
|
|
|
|
||||
|
|
2,539
|
|
|
3,807
|
|
(4)
|
$
|
62.316
|
|
9/6/2022
|
|
|
|
|
|
|
|
|
|
||||
|
|
1,200
|
|
|
4,800
|
|
(5)
|
$
|
71.410
|
|
2/21/2023
|
|
|
|
|
|
|
|
|
|
||||
|
|
1,200
|
|
|
4,800
|
|
(5)
|
$
|
72.040
|
|
9/10/2023
|
|
|
|
|
|
|
|
|
|
||||
|
|
—
|
|
|
5,750
|
|
(6)
|
$
|
79.890
|
|
2/19/2024
|
|
|
|
|
|
|
|
|
|
||||
|
|
—
|
|
|
5,750
|
|
(6)
|
$
|
80.400
|
|
9/9/2024
|
|
|
|
|
|
|
|
|
|
||||
|
|
|
|
|
|
|
|
|
1,125
|
|
(7)
|
96,593
|
|
(7)
|
|
|
|
|
||||||
|
|
|
|
|
|
|
|
|
1,125
|
|
(8)
|
96,593
|
|
(8)
|
|
|
|
|
||||||
|
|
|
|
|
|
|
|
|
1,440
|
|
(9)
|
123,638
|
|
(9)
|
|
|
|
|
||||||
|
|
|
|
|
|
|
|
|
1,440
|
|
(10)
|
123,638
|
|
(10)
|
|
|
|
|
||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
1,725
|
|
(11)
|
148,109
|
|
(11)
|
||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
1,725
|
|
(12)
|
148,109
|
|
(12)
|
||||||
|
(1)
|
Includes only those columns that related to outstanding equity awards at
2014
. All other columns have been omitted.
|
|
(2)
|
Vests in full on
11/01/2015
.
|
|
(3)
|
Vesting occurs 50% on each of
11/01/2015
and
11/01/2016
.
|
|
(4)
|
Vesting occurs 33 1/3% on each of
12/10/2015
,
12/09/2016
, and
12/08/2017
. These grant agreements include a provision that allows for continued vesting for a period of 36 months from the date of termination if certain age and service criteria are met.
|
|
(5)
|
Vesting occurs 25% on each of
12/10/2015
,
12/09/2016
,
12/08/2017
, and
12/10/2018
. These grant agreements include a provision that allows for continued vesting for a period of 36 months from the date of termination if certain age and service criteria are met.
|
|
(6)
|
Vesting occurs 20% on each of
12/10/2015
,
12/09/2016
,
12/08/2017
,
12/10/2018
, and
12/10/2019
. These grant agreements include a provision that allows for continued vesting for a period of 36 months from the date of termination if certain age and service criteria are met.
|
|
(7)
|
At its February 2013 meeting, the Executive Compensation Committee certified that the Company had achieved the operating margin performance target for the performance period January 1, 2012 to December 31, 2012; therefore, vesting of these restricted stock units will occur 33 1/3% on each of
12/10/2015
,
12/09/2016
, and
12/08/2017
. These grant agreements include a provision that allows for continued vesting for a period of 36 months from the date of termination if certain age and service criteria are met. The market value of these units was calculated using the closing market price per share of Price Group's common stock on
December 31, 2014
.
|
|
(8)
|
Through a unanimous written consent in August 2013, the Executive Compensation Committee certified that the Company had achieved the operating margin performance target for the performance period July 1, 2012 to June 30, 2013; therefore, vesting of these restricted stock units will occur 33 1/3% on each of
12/10/2015
,
12/09/2016
, and
12/08/2017
. These grant agreements include a provision that allows for continued vesting for a period of 36 months from the date of termination if certain age and service criteria are met. The market value of these units was calculated using the closing market price per share of Price Group's common stock on
December 31, 2014
.
|
|
(9)
|
At its February 2014 meeting, the Executive Compensation Committee certified that the Company had achieved the operating margin performance target for the performance period January 1, 2013 to December 31, 2013; therefore, vesting of these restricted stock units will occur 25% on each of
12/10/2015
,
12/09/2016
,
12/08/2017
, and
12/10/2018
. These grant agreements include a provision that allows for continued vesting for a period of 36 months from the date of termination if certain age and service criteria are met. The market value of these units was calculated using the closing market price per share of Price Group's common stock on
December 31, 2014
.
|
|
(10)
|
At its September 2014 meeting, the Executive Compensation Committee certified that the Company had achieved the operating margin performance target for the performance period July 1, 2013 to June 30, 2014; therefore, vesting of these restricted stock units will occur 25% on each of
12/10/2015
,
12/09/2016
,
12/08/2017
, and
12/10/2018
. These grant agreements include a provision that allows for continued vesting for a period of 36 months from the date of termination if certain age and service criteria are met. The market value of these unearned units was calculated using the closing market price per share of Price Group's common stock on
December 31, 2014
.
|
|
(11)
|
At its February 2015 meeting, the Executive Compensation Committee certified that the Company had achieved the operating margin performance target for the performance period January 1, 2014 to December 31, 2014; therefore, vesting of these restricted stock units will occur 20% on each of
12/10/2015
,
12/09/2016
,
12/08/2017
,
12/10/2018
and
12/10/2019
. These grant agreements include a provision that allows for continued vesting for a period of 36 months from the date of termination if certain age and service criteria are met. The market value of these units was calculated using the closing market price per share of Price Group's common stock on
December 31, 2014
.
|
|
(12)
|
If the Company's operating margin for the twelve month performance period July 1, 2014 to June 30, 2015, is at least 100% of the average operating margin of a designated peer group, all of these restricted stock units will vest 20% on each of
12/10/2015
,
12/09/2016
,
12/08/2017
,
12/10/2018
, and
12/10/2019
. These grant agreements include a provision that allows for continued vesting for a period of 36 months from the date of termination if certain age and service criteria are met. The market value of these unearned units was calculated using the closing market price per share of Price Group's common stock on
December 31, 2014
.
|
|
|
Option Awards
|
|
Stock Awards
|
|||||||||
|
Name
|
Number of Shares Acquired on Exercise
(1)(5)
|
|
Value Realized on Exercise
(2)
|
|
Number of Shares Acquired on Vesting
(3)
|
Value Realized on Vesting
(3)
|
||||||
|
James A.C. Kennedy
|
102,008
|
|
(4)
|
$
|
5,183,429
|
|
|
5,160
|
|
$
|
433,182
|
|
|
Brian C. Rogers
|
20,210
|
|
|
$
|
1,114,231
|
|
|
5,160
|
|
$
|
433,182
|
|
|
Edward C. Bernard
|
108,672
|
|
|
$
|
5,148,002
|
|
|
5,160
|
|
$
|
433,182
|
|
|
William J. Stromberg
|
94,791
|
|
|
$
|
3,395,346
|
|
|
4,875
|
|
$
|
409,256
|
|
|
Kenneth V. Moreland
|
|
|
|
|
|
|
1,470
|
|
$
|
123,407
|
|
|
|
(1)
|
Represents the total number of shares underlying the exercised stock options.
|
|
(2)
|
Computed using the difference between the market price of Price Group's common stock on the date of exercise and the exercise price, multiplied by the number of shares acquired.
|
|
(3)
|
Reflects the number of shares underlying the performance-based restricted stock units earned and vested. The value realized on vesting is computed using the closing market price per share of Price Group's common stock on the vest date multiplied by the number of restricted stock units vesting. The following table shows the aggregate restricted stock units for the NEOs by date of award:
|
|
Date of Award
|
|
Performance Period Completion Date
|
|
Number of Shares Acquired on Vesting
|
|
Market Price on Vest Date
|
|
Value Realized on Vesting
|
|
2/23/2012
|
|
12/31/2012
|
|
6,150
|
|
$83.95
|
|
$516,293
|
|
9/6/2012
|
|
6/30/2013
|
|
5,625
|
|
$83.95
|
|
$472,219
|
|
2/21/2013
|
|
12/31/2013
|
|
5,610
|
|
$83.95
|
|
$470,960
|
|
9/10/2013
|
|
6/30/2014
|
|
4,440
|
|
$83.95
|
|
$372,738
|
|
(4)
|
Of these shares,
60,937
shares were exercised by a limited liability company controlled by Mr. Kennedy. The value realized on these exercises was
$3,075,612
.
|
|
(5)
|
For some of the NEOs, the number of shares actually acquired was less than the number presented in the table above as a result of tendering shares for payment of the exercise price and the withholding of shares to pay taxes. The total net shares received by those NEOs is as follows:
|
|
Name
|
Net Shares Acquired on Exercise
|
|
Net Shares Acquired on Vesting
|
|
James A.C. Kennedy
|
100,930
|
|
2,617
|
|
Edward C. Bernard
|
32,025
|
|
2,549
|
|
William J. Stromberg
|
23,817
|
|
2,409
|
|
Plan Category
|
Number of Securities to be Issued Upon Exercise of Outstanding Options and Settlement of Restricted Stock Units (a)
|
|
Weighted-Average Exercise Price of Outstanding Options
|
|
Number of Securities Remaining Available for Future Issuance Under Equity Compensation Plans (excluding securities reflected in column (a))
|
|
||||
|
Equity compensation plans approved by stockholders
(3)
|
30,816,534
|
|
(1)
|
$
|
56.95
|
|
(1)
|
17,514,148
|
|
(2)
|
|
Equity compensation plans not approved by stockholders
|
—
|
|
|
|
|
—
|
|
|
||
|
Total
|
30,816,534
|
|
|
$
|
56.95
|
|
|
17,514,148
|
|
|
|
(1)
|
Includes
1,055,015
shares that may be issued upon settlement of outstanding restricted stock units. The weighted-average exercise price pertains only to the
29,761,519
outstanding options.
|
|
(2)
|
Includes shares that may be issued under our 2007 Non-Employee Director Equity Plan and 2012 Long-Term Incentive Plan (2012 Plan), and
3,412,508
shares that may be issued under our Employee Stock Purchase Plan. No shares have been issued under the Employee Stock Purchase Plan since its inception; all plan shares have been purchased in the open market
.
The number of shares available for future issuance will increase under the terms of the 2012 Plan as a result of all common stock repurchases that we make from proceeds generated by stock option exercises that occur after the inception of the 2012 Plan. The 2012 Plan allows for the grant of stock options, stock appreciation rights, and full-value awards.
|
|
(3)
|
On February 19, 2015, the Board of Directors declared a special dividend of $2.00 per share payable April 23, 2015, to stockholders of record as of the close of business on April 9, 2015. In accordance with the anti-dilution provisions of our long-term incentive plans, an equitable adjustment will be made to all outstanding options to neutralize the impact of the special dividend. Additionally, these anti-dilution provisions require all numerical limits within the plans to be adjusted to reflect the impact of the special dividend. These adjustments will be effective on the special dividend's ex-dividend date (April 7, 2015).
|
|
Type of Fee
|
2013
|
2014
|
||||
|
Audit Fees
(1)
|
$
|
1,435,152
|
|
$
|
1,716,801
|
|
|
Audit-Related Fees
(2)
|
104,444
|
|
104,761
|
|
||
|
Tax Fees
(3)
|
798,493
|
|
943,526
|
|
||
|
All Other Fees
(4)
|
138,953
|
|
108,120
|
|
||
|
|
$
|
2,477,042
|
|
$
|
2,873,208
|
|
|
(1)
|
Aggregate fees charged for annual audits, quarterly reviews, and the reports of the independent registered public accounting firm on internal control over financial reporting as of December 31,
2013
and
2014
.
|
|
(2)
|
Aggregate fees charged for assurance and related services that are reasonably related to the performance of the audit and are not reported as Audit Fees. In
2013
and
2014
, these services included audits of several affiliated entities, including the corporate retirement plans, the T. Rowe Price Foundation, Inc., and fees for consultations concerning financial accounting and reporting matters. The fees in
2014
also include services provided in relation to the filing of Form S-8 to register securities under the Supplemental Savings Plan.
|
|
(3)
|
Aggregate fees charged for tax compliance, planning, and consulting. These amounts include tax consulting of
$291,176
in
2013
and
381,923
in
2014
.
|
|
(4)
|
Both
2013
and
2014
include fees for KPMG's performance of attestation engagements related to our compliance with the Global Investment Performance Standards and regulations in countries in which we hold licenses, fees related to executive education, and a subscription to information to assist in complying with the Office of Foreign Assets Control and EU regulations. In 2013, fees also include a market analysis performed by KPMG.
|
|
•
|
Any audit or non-audit service to be provided to Price Group by the independent registered public accounting firm must be submitted to the Audit Committee for review and approval. The proposed services are submitted on the Audit Committee's “Independent Registered Public Accounting Firm Audit and Non-Audit Services Request Form” with a description of the services to be performed, fees to be charged, and affirmation that the services are not prohibited under Section 201 of the Sarbanes-Oxley Act of 2002. The form must be approved by Price Group's chief executive officer, chief financial officer, or director of internal audit prior to submission to the Audit Committee.
|
|
•
|
The Audit Committee in its sole discretion then approves or disapproves the proposed services and documents such approval, if given, by signing the approval form. Pre-approval actions taken during Audit Committee meetings are recorded in the minutes of the meetings.
|
|
•
|
Any audit or non-audit service to be provided to Price Group which is proposed between meetings of the Audit Committee will be submitted to the Audit Committee chairman on a properly completed “Independent Registered Public Accounting Firm Audit and Non-Audit Services Request Form” for the chairman's review and pre-approval and will be included as an agenda item at the next scheduled Audit Committee meeting.
|
|
Robert F. MacLellan, Chairman
|
|
Mark S. Bartlett
|
|
Dr. Freeman A. Hrabowski, III
|
|
Dwight S. Taylor
|
|
1)
|
Stockholders may send correspondence, which should indicate that the sender is a stockholder, to our Board of Directors or to any individual director by mail to T. Rowe Price Group, Inc., c/o Chief Legal Officer, P.O. Box 17134, Baltimore, MD 21297-1134, or by e-mail to stockholdercommunications@troweprice.com or by Internet at
trow.client.shareholder.com/contactBoard.cfm
.
|
|
2)
|
Our Chief Legal Officer will be responsible for the first review and logging of this correspondence. The officer will forward the communication to the director or directors to whom it is addressed unless it is a type of correspondence which the Nominating and Corporate Governance Committee has identified as correspondence which may be retained in our files and not sent to directors.
|
|
3)
|
The log of stockholder correspondence will be available to members of the Nominating and Corporate Governance Committee for inspection. At least once each year, the Chief Legal Officer will provide to the Nominating and Corporate Governance Committee a summary of the communications received from stockholders, including the communications not sent to directors in accordance with screening procedures approved by the Nominating and Corporate Governance Committee.
|
No information found
* THE VALUE IS THE MARKET VALUE AS OF THE LAST DAY OF THE QUARTER FOR WHICH THE 13F WAS FILED.
| FUND | NUMBER OF SHARES | VALUE ($) | PUT OR CALL |
|---|
| DIRECTORS | AGE | BIO | OTHER DIRECTOR MEMBERSHIPS |
|---|
No information found
No Customers Found
No Suppliers Found
Price
Yield
| Owner | Position | Direct Shares | Indirect Shares |
|---|